See what Modern Medicine knows about Diabetes Treatment
1. Ranolazine would have all the following effects in diabetic patients with cardiovascular disease, EXCEPT:
2. Statins increase the risk of incident diabetes in which patient?
3. Type 2 diabetes is an independent risk factor for osteoarthritis. True or False?
4. What cutoff score of the PHQ-9 provides the best sensitivity and acceptable specificity in screening for depression in patients with type 2 diabetes?
5. The withholding of carbohydrate in the first meal following a fast in patients with type 2 diabetes significantly:
Answer Key:
1. None of the answers is correct – all are effects. Ranolazine has many applications beyond that for which it was approved – chronic angina.
2. Both answers are correct. However, statin use also decreases overall mortality in both types of patients, outweighing the small (19-24%) risk of diabetes. I don't think 24% is a small risk. It is almost one quarter.
3. True. Osteoarthritis is also associated with obesity and metabolic syndrome. I recommend Xymogen's SynovX Metabolic for the overweight patient with metabolic insulin resistance and osteoarthritis.
3. True. Osteoarthritis is also associated with obesity and metabolic syndrome. I recommend Xymogen's SynovX Metabolic for the overweight patient with metabolic insulin resistance and osteoarthritis.
4. 5. The PHQ-9 can be used in 2-stage screening in primary care to identify patients with type 2 diabetes for further psychological evaluation.
5. Decreases peak blood glucose [Gmax] after the meal. Overall daily control is not significantly improved.
5. Decreases peak blood glucose [Gmax] after the meal. Overall daily control is not significantly improved.
For full information see: Pedersen E, et al. Am J Clin Nutr. 2016;104(5):1285-1291.
